Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 20 mg
Johnson & Johnson Pacific Pty Ltd
Nicotine polacrilex
Gum, chewing
Excipient Ingredients: quinoline yellow aluminium lake; pregelatinised maize starch; acesulfame potassium; polysorbate 80; sodium carbonate; Carnauba Wax; xylitol; menthol; hypromellose; sucralose; titanium dioxide; Peppermint Oil; light magnesium oxide; Flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides
Buccal
370, 200, 270, 15, 400, 285, 355, 255, 150, 105, 325, 340, 240, 30, 315, 180, 300, 210, 225, 75, 385, 310
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: A square, coated, cream coloured pice of gum with a minty odour; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2009-10-07